NIH-funded research NIH-funded research

Understanding how the immune system can be adjusted to fight a common lung infection.

Official title: Tuning complement-mediated immunity in aspergillosis: a systems medicine approach

Funded at University of Florida · NIH-10996181 · Data updated 2026-11-12

This study is looking at how a part of the immune system can help fight a serious fungal infection called invasive aspergillosis, especially in people with weakened immune systems, and aims to find better treatments that can reduce lung damage while still protecting against the infection.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startDecember 7, 2023
Project endNovember 30, 2028
Funding year2025
Award (this year)$116,844
NIH project number5K25AI175668-02
Project IDNIH-10996181 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are immunocompromised patients at risk for invasive aspergillosis.

Less likely to help

Patients with non-fungal lung infections or those not immunocompromised may not benefit from this research.

What this research studies

This research investigates the role of the immune system's complement pathway in invasive aspergillosis, a serious fungal infection affecting immunocompromised patients. It aims to understand how complement activation can both protect against infections and contribute to lung injury and inflammation. By using mathematical modeling, the study seeks to design effective therapies that can intervene in the harmful interactions between pulmonary hemorrhage and complement activation. This approach may lead to new treatment strategies for managing pulmonary aspergillosis.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that improve outcomes for patients suffering from invasive aspergillosis.

How similar studies have gone: Previous research has shown promise in using complement inhibitors for treating similar conditions, indicating potential for success in this approach.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Sordo Vieira, Luis Alfonso — University of Florida
  • Study coordinator: Sordo Vieira, Luis Alfonso

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.